This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Pharma Cinq, LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jeffrey A. Miller: Inventor of an Amorphous Uridine Triacetate Formulation
Introduction
Jeffrey A. Miller is an inventor based in Lincoln University, Pennsylvania. His patent work includes a pharmaceutical formulation designed to support high uridine loading, stability, and oral bioavailability.
Latest Patents
Miller is associated with 1 patent, titled “Uridine Triacetate Amorphous Formulation.” The patent describes a dispersion of amorphous uridine triacetate in Hypromellose Acetate Succinate-MG, optionally combined with Copovidone. The disclosed compositions are intended to provide high uridine loading, good stability, and oral bioavailability.
Career Highlights
Miller is associated with Pharma Cinq, LLC. His patent reflects work on formulation approaches for delivering uridine triacetate.
Collaborations
His listed coworkers include Michael Kevin Bamat and Yi Gao.
Conclusion
Jeffrey A. Miller’s patent work focuses on an amorphous uridine triacetate formulation intended to combine high drug loading with stability and oral bioavailability.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile